Bunkerhill MAC vs EchoGo® Heart Failure
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Bunkerhill MAC, specializes in detecting and quantifying mitral annular calcification on CT scans to identify cardiovascular risk. In contrast, Tool B, EchoGo® Heart Failure, analyzes echocardiograms to detect heart failure with preserved ejection fraction, supporting its diagnosis. While both are FDA-cleared AI solutions for cardiology and clinical decision support, they address distinct cardiac conditions using different imaging modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Bunkerhill MAC is an FDA-cleared AI algorithm that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification. EchoGou00ae Heart Failure is an FDA-cleared AI platform that analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF).
Bunkerhill MAC analyzes routine, non-gated chest CT scans. EchoGou00ae Heart Failure analyzes routine echo video clips, specifically an apical 4-chamber view of the heart with an ejection fraction u226550%.
Bunkerhill MAC is cloud-based and integrates with existing EHRs and clinical systems via the Carebricks platform, supporting automated workflows for follow-up and care coordination. EchoGou00ae Heart Failure is also cloud-based and integrates seamlessly with existing workflows and IT stacks, using a DICOM workflow for report delivery to PACS.
EchoGou00ae Heart Failure delivers insights within 20 minutes. The provided information for Bunkerhill MAC does not specify a turnaround time for results.
For Bunkerhill MAC, pricing information requires direct contact with the company. EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers.
Bunkerhill MAC was developed and validated through a multi-institutional research consortium. EchoGou00ae Heart Failure is clinically validated with reported performance metrics of 90% sensitivity and 86% specificity for HFpEF detection.
Bunkerhill MAC provides quantification of MAC and integrates with the Carebricks platform for clinical reasoning and action, supporting automated workflows for follow-up and care coordination. EchoGou00ae Heart Failure provides AI-powered HFpEF detection, automated structured reports, and insights to support clinical decisions.